PT  - JOURNAL ARTICLE
AU  - Bai, Chunxue
AU  - Chotirmall, Sanjay H.
AU  - Rello, Jordi
AU  - Alba, George A.
AU  - Ginns, Leo C.
AU  - Krishnan, Jerry A.
AU  - Rogers, Robert
AU  - Bendstrup, Elisabeth
AU  - Burgel, Pierre-Regis
AU  - Chalmers, James D.
AU  - Chua, Abigail
AU  - Crothers, Kristina A.
AU  - Duggal, Abhijit
AU  - Kim, Yeon Wook
AU  - Laffey, John G.
AU  - Luna, Carlos M.
AU  - Niederman, Michael S.
AU  - Raghu, Ganesh
AU  - Ramirez, Julio A.
AU  - Riera, Jordi
AU  - Roca, Oriol
AU  - Tamae-Kakazu, Maximiliano
AU  - Torres, Antoni
AU  - Watkins, Richard R.
AU  - Barrecheguren, Miriam
AU  - Belliato, Mirko
AU  - Chami, Hassan A.
AU  - Chen, Rongchang
AU  - Cortes-Puentes, Gustavo A.
AU  - Delacruz, Charles
AU  - Hayes, Margaret M.
AU  - Heunks, Leo M.A.
AU  - Holets, Steven R.
AU  - Hough, Catherine L.
AU  - Jagpal, Sugeet
AU  - Jeon, Kyeongman
AU  - Johkoh, Takeshi
AU  - Lee, May M.
AU  - Liebler, Janice
AU  - McElvaney, Gerry N.
AU  - Moskowitz, Ari
AU  - Oeckler, Richard A.
AU  - Ojanguren, Iñigo
AU  - O'Regan, Anthony
AU  - Pletz, Mathias W.
AU  - Rhee, Chin Kook
AU  - Schultz, Marcus J.
AU  - Storti, Enrico
AU  - Strange, Charlie
AU  - Thomson, Carey C.
AU  - Torriani, Francesca J.
AU  - Wang, Xun
AU  - Wuyts, Wim
AU  - Xu, Tao
AU  - Yang, Dawei
AU  - Zhang, Ziqiang
AU  - Wilson, Kevin C.
TI  - Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
AID  - 10.1183/16000617.0287-2020
DP  - 2020 Sep 30
TA  - European Respiratory Review
PG  - 200287
VI  - 29
IP  - 157
4099  - http://err.ersjournals.com/content/29/157/200287.short
4100  - http://err.ersjournals.com/content/29/157/200287.full
SO  - EUROPEAN RESPIRATORY REVIEW2020 Sep 30; 29
AB  - Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby improving outcomes and facilitating future research.Methods An International Task Force was composed and agreement regarding courses of action was measured using the Convergence of Opinion on Recommendations and Evidence (CORE) process. 70% agreement was necessary to make a consensus suggestion.Results The Task Force made consensus suggestions to treat patients with acute COVID-19 pneumonia with remdesivir and dexamethasone but suggested against hydroxychloroquine except in the context of a clinical trial; these are revisions of prior suggestions resulting from the interim publication of several randomised trials. It also suggested that COVID-19 patients with a venous thromboembolic event be treated with therapeutic anticoagulant therapy for 3 months. The Task Force was unable to reach sufficient agreement to yield consensus suggestions for the post-hospital care of COVID-19 survivors. The Task Force fell one vote shy of suggesting routine screening for depression, anxiety and post-traumatic stress disorder.Conclusions The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities.For patients with acute COVID-19 pneumonia who require oxygen support, the International Task Force made suggestions for remdesivir and dexamethasone, but against hydroxychloroquine. Post-discharge management of COVID-19 survivors is a research priority. https://bit.ly/32B96uI